Treating inflammatory bowel disorder by delivering microRNAs

August 28, 2018

Inflammatory bowel disease (IBD), such as Crohn disease and ulcerative colitis, are chronic inflammatory diseases of unknown cause, and the number of IBD patients is on the rise.

Various inflammatory cytokines, including TNF-α and interleukin-6 (IL6), damage the intestinal wall, causing IBD. Thus, the cytokine signaling pathway has become a therapeutic target.

Several types of microRNAs (miRNAs) to suppress the production of inflammatory cytokines have been clarified; however, there were no methods for efficiently and stably delivering miRNAs to the affected area. miRNAs can be unstable in the blood, reducing their transfection efficiency to the target cells, so the use of miRNAs for treating IBD has rarely been attempted.

Osaka University researchers efficiently delivered miRNAs to immune response cells in inflamed intestinal tracts using a super carbonate apatite (sCA), which had been shown to be highly effective in the delivery of nucleic acids to solid tumors, demonstrating the efficacy of sCA in the prevention and treatment of colitis in mice. Their research results were published in Molecular Therapy-Nucleic Acids.

The researchers performed systemic administration of RNA (miR)-29a and miR-29b (both of which suppress inflammatory cytokines) loaded on sCA to IBD model mice. Although miRNAs didn't accumulate much in the inflamed intestinal tracts, inflammatory cytokines were reduced, exhibiting the effects of prevention and treatment of colitis.

In addition, it was found that miRNAs loaded on sCA were efficiently delivered to the inflamed intestinal tracts' dendritic cells (DCs), which play a central role in immune responses, suppressing the production of inflammatory cytokines.

This study clarified that the sCA functioned as a unique system for delivering nucleic acid-based medicines such as miRNAs to DCs in the affected area to suppress inflammatory reaction at the molecular level, exhibiting the effects of prevention and treatment of colitis.

Corresponding author Hirofumi Yamamoto says, "Our technique to deliver miRNAs to DCs, major players in immune responses, will shape the future of medical care. sCA can be used to treat a wide range of immunity and allergic disorders caused by immune responses. The results of our study will lead to the development of new drugs for treating these disorders."
-end-
The Article, "Super carbonate apatite-microRNA complex inhibits dextran sodium sulfate-induced colitis" was published in Molecular Therapy-Nucleic Acids, https://doi.org/10.1016/j.omtn.2018.07.007

Osaka University was founded in 1931 as one of the seven imperial universities of Japan and now has expanded to one of Japan's leading comprehensive universities. The University has now embarked on open research revolution from a position as Japan's most innovative university and among the most innovative institutions in the world according to Reuters 2015 Top 100 Innovative Universities and the Nature Index Innovation 2017. The university's ability to innovate from the stage of fundamental research through the creation of useful technology with economic impact stems from its broad disciplinary spectrum.
Website: http://resou.osaka-u.ac.jp/en/top

Osaka University

Related Micrornas Articles from Brightsurf:

Breaking it down: How cells degrade unwanted micrornas
UT Southwestern researchers have discovered a mechanism that cells use to degrade microRNAs (miRNAs), genetic molecules that regulate the amounts of proteins in cells.

Is the COVID-19 virus pathogenic because it depletes specific host microRNAs?
Why is the COVID-19 virus deadly, while many other coronaviruses just cause colds?

Intracellular biopsy technique for fast microRNAs profiling in living cells
MicroRNAs (miRNAs) are gaining more attention in researches. To achieve fast and highly sensitive profiling of miRNAs, a research team from City University of Hong Kong (CityU) has developed a novel high-throughput intracellular biopsy technique that isolates targeted miRNAs from living cells within around 10 minutes by using diamond nanoneedles.

The function of new microRNAs are identified in Salmonella and Shigella infections
The research, published in Nature Microbiology, could help the search for more effective medicine and delves deeper into understanding the role of microRNAs in gene expression.

Protecting damaged hearts with microRNAs
Once the heart is formed, its muscle cells have very limited ability to regenerate.

A role for microRNAs in social behavior
Researchers have uncovered a microRNA cluster that regulates synaptic strength and is involved in the control of social behavior in mammals.

Genomic study finds a new role for microRNAs as predictors of Crohn's disease progression
A new study led by UNC School of Medicine researchers and has found that a set of biomolecules known as microRNAs, specifically microRNA-31 (miR-31), can help predict which patients with Crohn's disease are at higher risk for the development of severe problems that may require surgical removal of the large intestine.

Treating inflammatory bowel disorder by delivering microRNAs
Osaka University researchers efficiently delivered miRNAs to immune response cells in inflamed intestinal tracts using a super carbonate apatite (sCA), which had been shown to be highly effective in the delivery of nucleic acids to solid tumors, demonstrating the efficacy of sCA in the prevention and treatment of colitis in mice.

New screening approach reveals importance of microRNAs in papillomavirus life cycle
The discovery of microRNAs encoded by papillomaviruses supports the important role of these small molecules in persistent infection, according to a study published July 26 in the open-access journal PLOS Pathogens.

Magnetically applied MicroRNAs could one day help relieve constipation
Micro metal beads and magnets help deliver a biologic where it's needed to improve constipation or rectoanal incontinence in animal models of the disorders.

Read More: Micrornas News and Micrornas Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.